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In October of 2018 PLOS Biology celebrated its 15-year anniversary. Our corpus includes foun-
dational works in all aspects of the biological sciences, from cognitive neuroscience to conser-
vation ecology. The editors, both staff and Academic, are extremely proud of the quality and
breadth of science published in our journal. PLOS Biology has also played a pivotal role within
the Open Access movement, which in the 15 years since our launch has exploded and contin-
ues to revolutionize science communication.
We commemorated our anniversary with a year-long celebration. Each month, one of our
hard-working and highly-respected Editorial Board Members contributed a blog post describ-
ing their favorite PLOS Biology article and its impact on the respective field. Here, we collect
these posts and featured manuscripts, which can also be found in this Collection [1].
These posts highlight the incredible diversity of science published in our journal. In addi-
tion to featuring our Research Articles, some of our Academic Editors chose to highlight non-
standard research content. Among the mix, Piali Sengupta wrote about an important article
featuring negative results, which reshaped how we think about pheromone signaling. Andrew
Read discussed one of the articles published in our Magazine section, which featured emerging
and forward-thinking theory on possible unforeseen outcomes of novel therapies. Jonathan
Kimmelman highlighted work from our Meta-Research section on the lack of rigor by ethical
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oversight committees. We hope you enjoy all of the posts and we look forward to many more
years of publishing cutting-edge science across all fields of biology.
January: Cell biology by Sandra Schmid
Watching a vesicle form
Living cells face a dilemma; in order to prevent the unregulated influx and efflux of molecules
they need a plasma membrane that is literally water-tight, but they also need to be able to take
up specific molecules such as proteins from their environment. One of the ways in which they
solve this problem is by the use of clathrin-mediated endocytosis.
This complex and highly regulated process involves a tightly orchestrated sequence of steps
that entails the formation of pits in the plasma membrane, coated with a basket-like array of
clathrin (known as clathrin-coated pits, or CCPs), followed by invagination, constriction, and
pinching-off to form clathrin-coated vesicles (CCVs).
This process requires not only the major coat proteins, clathrin and adaptor protein com-
plexes (AP2) and the GTPase dynamin, but a myriad endocytic accessory proteins (EAPs),
whose exact functions are still not clearly defined. Although studied for almost 50 years, the
true complexity of clathrin-mediated endocytosis was only recently revealed through the
advent of live cell microscopy to image the dynamics of CCPs.
For the PLOS Biology XV Collection I’ve chosen to highlight this article by Christien Merri-
field and co-workers [2] as it described a sophisticated and highly precise microscopy-based
method to detect the scission event that leads to CCV formation and maps the temporal hier-
archy of EAP recruitment to CCPs.
The method involved the use of transferrin receptors externally tagged with a pH-sensitive
GFP (TfR-phl); these were imaged by total internal reflection fluorescence microscopy in a
perfusion chamber in which the media is periodically cycled between pH 5 and pH 7. Imaging
was coordinated at 2-second intervals with each pH change, so that the appearance of pH
5-insensitive TfR-phl precisely marked the point of scission.
This elegant approach was used to comprehensively analyze the temporal hierarchy of
recruitment of 34 EAPs relative to the scission event, which allowed their classification into
functional modules temporally linked to CCP initiation and maturation, actin dynamics, scis-
sion, uncoating, and post-scission vesicle motility.
The article was and remains the highest resolution temporal map of the molecular events
governing the clathrin-mediated endocytosis process to date. In addition to the hierarchical
classification of EAPs, the article also revealed other key principles of CCP dynamics (Fig 1).
First, the kinetics, extent and frequency of EAP recruitment to CCPs, as well as the dynam-
ics of CCPs themselves were highly heterogenous. Merrifield reported that short-lived CCPs
often failed to sequester TfR-phl and thus unambiguously established that short-lived CCPs
were abortive events.
Second, in several cases Merrifield detected multiple, sequential fission events associated
with continuously detected clathrin structures. These were classified as ‘non-terminal events’
that likely reflect pinching-off of CCVs from the periphery of larger clathrin-coated structures.
Importantly, the recruitment signatures of EAPs to terminal vs non-terminal events were
indistinguishable, suggesting a common mechanism governing CCP maturation and scission.
Third, the work established a remarkable coordination between scission and uncoating of
the released vesicle.
This seminal article represents a significant leap in our understanding of vesicle trafficking
and questions raised by the study continue to be addressed by researchers today. What is the
significance and molecular basis for the dynamic and compositional heterogeneity of CCPs?
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How is uncoating so tightly coupled with membrane scission? What prevents the uncoating of
deeply invaginated CCPs? What determines the productive maturation versus early abortion
of CCPs?
February: Immunology by Avinash Bhandoola and Christelle Harly
The exquisite precision of T cell receptors
The vertebrate adaptive immune system can distinguish invaders from self with exquisite pre-
cision. The T cells, their immune receptors, and the antigenic ligands involved in this process
are well characterized, but how a T cell receptor (TCR) can distinguish between closely related
ligands, detect minute amounts of foreign antigens, and in turn trigger distinct downstream
signals, remains poorly understood. Through its TCR, a T cell can distinguish between self and
non-self ligands that differ by just a single amino acid, and T cells can be activated by a single
non-self peptide that might appear to be otherwise lost among millions of self molecules.
Understanding this remarkable discrimination is a major challenge in immunology.
Fig 1. Our view of clathrin-mediated endocytosis before (Ai) and after (Aii) Taylor et al.’s study. Image
reproduced under CC-BY 4.0 license, credit: 10.1371/journal.pbio.pbio.1000604
https://doi.org/10.1371/journal.pbio.3000180.g001
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In the foundational article that we have chosen to highlight for the PLOS Biology XV Collec-
tion, Gre´goire Altan-Bonnet and Ron Germain addressed this problem [3]. Using quantitative
measurements and mathematical models, they showed that the previously well-established
kinetic-proofreading model could not adequately explain the exquisite discrimination that T
cells are capable of. To improve upon it, they incorporated into this model a negative feedback
pathway previously suggested to sharpen the discrimination threshold between closely related
TCR ligands. The new model accurately predicted the behavior of T cell activation in response
to different TCR ligands, and accounted for the speed, sensitivity, and specificity of TCR-
dependent activation (Fig 2).
This model depicts the TCR signaling pathway as a tunable switch. The switch is provided
by two discrete states of ERK phosphorylation that the authors document for the first time and
propose to be an early correlate for T cell activation. The sensitivity and specificity of this
switch is tuned via the negative feedback loop by molecular players whose activity could be set
during development, and further modulated by additional signaling pathways downstream of
other receptors on T cells.
The work also provides an explanation for the seemingly counterintuitive behavior of
antagonistic TCR ligands. An agonist ligand activates a T cell response, but an antagonist
ligand is one that blocks activation by an agonist ligand. Such ligands are proposed to trigger
the negative feedback loop of a given TCR without reaching the threshold of activation, thus
antagonizing activation by the agonist ligand. The closer a non-agonist ligand is to reaching
the activation threshold, the more antagonistic it will appear. The function of antagonist
ligands is still unclear, but more recent work by Paul Franc¸ois & coworkers [4] derived a theo-
rem demonstrating how antagonism is in fact a phenotypic “spandrel” (Stephen Jay Gould’s
term) of sharp ligand discrimination. In other terms, the evolution of the negative feedback
that receptors need to achieve the necessary sensitivity and specificity also led to the appear-
ance of antagonism.
The model developed by Altan-Bonnet and Germain, which is an “adaptive kinetic proof-
reading” model, has endured the test of time. The negative feedback could apply to any recep-
tor and in fact could be a general scheme for any complex system performing a classification
task such as self/non-self discrimination in the adaptive or innate immune systems. Hence,
Fig 2. The model used by Altan-Bonnet and Germain of the core module of early events of TCR signaling. Image reproduced under CC-BY 4.0 license,
credit: 10.1371/journal.pbio.0030356
https://doi.org/10.1371/journal.pbio.3000180.g002
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this study focused on TCR signaling has general applications in immunology as well as in theo-
retical biological physics.
March: Biophysics and biomechanics by Anders Hedenstro¨m
How bats land head-over-heels
Flight in animals is energetically very costly, but because of its speed it can result in an overall
relatively low cost of transport that allows birds, bats and insects to perform seasonal migra-
tions. However, economic transport requires speeds where flight efficiency is high, allowing
the wings to generate aerodynamic forces of high lift and low drag. A lot of research related to
flight ecology has therefore concentrated on aerodynamic performance by animals, whereby
popular models of animal flight often are applied to birds and bats as if they are interchange-
able objects, despite their rather distinct flight morphologies [5].
For the PLOS Biology XV Collection I have chosen to highlight an article by Bergou and co-
workers [6] that focuses on inertial forces deployed by bats during their acrobatic approach to
landing head-over-heels as bats usually do. In this study, Bergou at al. investigated how bats
execute this acrobatic manoeuvre, exploiting asymmetric morphing of the wings to set up a
torque that causes the body to rotate (Fig 3). To land on a surface the bat needs to get a grip
with their tiny feet, which are interconnected to the wings via the inner wing membrane (the
plagiopatagium) and therefore quite immobile. Because the bat has to slow down just before
initiating the somersault, this prevents the use of aerodynamic forces–these are small anyway
at such low speeds, and the proximity to the landing site prevents vigorous flapping.
Previous observations had showed how bats do it, but to dig further into how inertial forces
replace aerodynamic forces, Bergoud et al. also analysed a simple model–a bat with rectangular
wings and simplified kinematics, but still capable of generating manoeuvres similar to those
Fig 3. Apparatus used by Bergou et al. for their study. The three high-speed cameras (A), running at 1,000 frames
per second, captured the motion of the bats as they landed on the ceiling pad (E). Image reproduced under CC-BY 4.0
license, credit: 10.1371/journal.pbio.1002297.
https://doi.org/10.1371/journal.pbio.3000180.g003
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seen in the real animal (Fig 4). The model was also extended to a “fully articulated model” with
similar results.
The key to the inertia-related manoeuvres in bats is their relatively heavy wings, making it
possible to set up a torque through asymmetric wing morphing. This may not be possible for
other flying animals such as birds and insects, where wings are lighter than in bats. Another
reason why inertia-related manoeuvres may not be useful to flies and hummingbirds is that
they have also relatively stiff wings that prevent excessive morphing.
This article shows how complicated tasks such as everyday landing manoeuvres in bats con-
sist of a rapid transition from aerodynamic-based cruising flight to an inertia-based somersault
in free-fall under the ceiling. The study may also shed new light on our understanding of the
evolution of flight, by investigating how incipient flight manoeuvres in a proto-flyer can be
executed by using forelimbs with little or no aerodynamic lift.
April: Microbiology by Michael Laub
What happens when the antibiotic 1–2 punch backfires?
The rise of antibiotic resistance is a frightening reality. In response, many have insisted that we
must find and develop new antibiotics. But developing even a single new antibiotic–one that is
both safe and effective–is a daunting task that could take decades, if successful at all. Indeed,
given the risks and the lack of financial incentives, many pharmaceutical companies have
completely abandoned their antibiotic development efforts. This could be grim news with dire
consequences for human health. But fortunately, there is evidence that we can deploy the cur-
rent arsenal of antibiotics more effectively to circumvent resistance and the need for new
antibiotics.
The article that I chose to highlight for the PLOS Biology XV Collection, “When the Most
Potent Combination of Antibiotics Selects for the Greatest Bacterial Load: The Smile-Frown
Transition”, tackles this issue [7]. In this article, Robert Beardmore and colleagues focus on
understanding how combinations of antibiotics impact bacterial growth, with some rather
counterintuitive results.
Fig 4. Top row: Movie stills taken as a Seba’s short-tailed bat (Carollia perspicillata) tries–and fails–to land on the ceiling. Bottom row: 3D reconstruction of this
activity. Image reproduced under CC-BY 4.0 license, credit: 10.1371/journal.pbio.1002297.
https://doi.org/10.1371/journal.pbio.3000180.g004
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Combination therapy is a popular and powerful means of combatting many bacterial path-
ogens, viral infections, and even cancer. The simple, and perhaps simplistic, notion is that
treating a bacterial infection with two antibiotics must be better than one. In particular, for
two antibiotics that are initially synergistic, i.e. the combination suppresses growth more effec-
tively than either does alone, it would seem logical that more is better. Continued treatment
with those two antibiotics seems like the natural course of action to eradicate the bacteria. But
what this article demonstrates is the exact opposite! What is initially a powerful combination
can, in fact, lead to the highest load of bacteria in the long-run.
How do we make sense of such a counterintuitive result? Beardmore’s group showed that
the key is to consider the competition that occurs between drug-susceptible and drug-resistant
members of a population. Antibiotic-resistant mutants readily arise within almost any popula-
tion of bacteria. If a population containing both susceptible and resistant mutants is treated
with two antibiotics, the susceptible majority is, as expected, rapidly wiped out. But this also
removes any competition for the resistant minority, enabling them to quickly grow and prolif-
erate. In contrast, treating the same mixed population with a single antibiotic can be less effec-
tive initially as the susceptible bacteria aren’t eliminated as quickly, and their continued (albeit
impeded) growth helps keep the resistant bacteria in check.
This article demonstrates how such a competition-based model can, in principle, compli-
cate the long-term dynamics of antibiotic-treated bacterial populations, leading to what they
term a ‘smile-frown’ transition. To explain: if one plots the density of bacteria on the y-axis
and various combinations of two antibiotics on the x-axis, ranging from a 100:0 split of antibi-
otic 1:antibiotic 2, to an even 50:50 split, to 0:100, the result is a ‘smile’, at least initially (Fig 5).
But what the modeling suggests is that over time, this curve is inverted to a ‘frown’ as the 50:50
split goes from being the best combination to the worst.
The article demonstrates that this smile-frown transition occurs in real populations of
Escherichia coli. And they show, as predicted from their modeling, that the transition depends
Fig 5. A figure from Pena-Miller et al showing (A) how a synergistic combination of antibiotics can be initially
optimal, but produce maximal growth in the long-term. (B) When the combinations range from monotherapy
with one drug, to a 50:50 split, to a monotherapy with the other drug, the initial ‘smile’ gets flipped to a ‘frown’
over time. Image reproduced under CC-BY 4.0 license, credit: 10.1371/journal.pbio.1001540.
https://doi.org/10.1371/journal.pbio.3000180.g005
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on the emergence of antibiotic resistance, frequently through duplication of a drug efflux gene.
Eliminating this gene largely eliminated the smile-frown transition.
This work by the Beardmore group is a beautiful demonstration of how easily our initial
intuition can lead us astray and how complex dynamics can emerge in seemingly simple sys-
tems. Whether the exact principles learned from this article will apply in the context of clini-
cally-relevant infections remains to be seen. But at a minimum, this article highlights the
profound importance of careful and quantitative analyses in thinking about how we deploy
antibiotic combinations. Such efforts might just be a better and more practical strategy in the
coming era of antibiotic resistance than waiting for a new miracle drug.
May: Ecology by Georgina Mace
Effective conservation requires science-based decisions
The efforts made by conservationists to preserve vulnerable species and sustain critical ecosys-
tem services face increasing challenges. Funding is limited, pressures on natural environments
are escalating, and competing demands for the use of land and sea are intensifying. So how do
conservation practitioners decide what to do with the limited resources available to them, and
how might their actions be more efficiently designed?
The two papers that I have selected to highlight for the PLOS Biology XV Collection come
from the Possingham group at the University of Queensland and introduce a formal basis for
making conservation decisions [8,9]. The case studies in both these articles suggest that the
most obvious actions may not be the best, and the authors present analytical approaches to
improve decision-making. These approaches require a certain amount of scientific under-
standing of the system but applying these techniques to guide conservation actions will provide
much better outcomes compared to relying on traditional wisdom.
The traditional approach for conservation is, first and foremost, to protect existing habitat.
The alternative—habitat restoration—can be very costly, and recent experience reveals that the
full suite of species and ecosystem services may be recovered only slowly over time. But even
well-managed intact areas inevitably degrade over time due to growing anthropogenic pres-
sures and environmental change. On the other hand, well-implemented restoration projects
can deliver optimal conditions for certain species or ecosystem services. Rather surprisingly,
these articles show that as restoration techniques improve, there are often circumstances
where restoration should be prioritised over protection.
The studies use decision theory, employing resource allocation optimisation models given a
fixed budget and a specific desired outcome. The articles are significant for putting conserva-
tion practice onto a more formal scientific and evidence-based footing. They are able to do this
by taking a few specific steps that are not common practice in many conservation efforts, but
perhaps should be.
The first critical step is to have a clearly defined outcome that is required for the area or
habitat under consideration. Possingham et al (2015) [8] investigate two case studies. In the
first, the objective is to maximise the storm protection services of intact mangrove ecosystems
in the Coral Triangle, and in the second the objective is to minimise bird species extinctions in
the Atlantic forest of Paraguay. The second article (Saunders et al. 2017) [9] investigates the
more complex case of coastal ecosystems in Australia where the objective is to restore func-
tional seagrass beds that are strongly affected by land-based sediment flows (Fig 6). Thus there
are four choices for conservation actions for this system: restoration or recovery of land or
ocean habitats. In each case study there is a fixed budget allocation over the next 30 or 40
years. The final input in each case is a dynamic and temporally explicit landscape or land-
scape-seascape model that integrates the costs and benefits of restoration or protection to find
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the optimal decision in each case. These three elements–an explicit objective, a fixed budget,
and an effective model of the system are not often available, but when they are the results can
be very influential.
In the mangrove case, restoration is favoured over protection because the storm protection
service requires intact mangrove forest and restoration achieves a reduction in degradation
more quickly, even though it is more costly. In the rapidly degrading Paraguayan forests, the
optimal strategy is protection for the first 20 years, effectively reducing the rate area of
degraded forest, but thereafter a switch to restoration achieves the greatest reduction in the
number of bird extinctions. In the coastal study the surprising result is that the optimal strat-
egy for restoring intact seagrass beds is restoration in the marine environment, and not
addressing pollution sources on the land. This turns out to be more effective over the long
term despite its higher costs. These conclusions are all sensitive to a number of input assump-
tions which are explored in the articles.
Crucially, the explicit optimisation models may not be possible in many real-world situa-
tions–they depend on substantial inputs from ecology and economics as well as practical expe-
rience. But both articles also use sensitivity analysis to explore different ecological contexts and
provide simple rules of thumb to aid decision-making in practice. In real world cases there are
often multiple objectives which complicate the analysis, but need not rule out adopting the
approach.
Fig 6. Map of the Moreton Bay area of Queensland, Australia, site of the seagrass case study in Saunders et al. Image reproduced
under CC-BY 4.0 license, credit: 10.1371/journal.pbio.2001886.
https://doi.org/10.1371/journal.pbio.3000180.g006
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Conservation practice is often far from evidence-based, but certainly should be. These arti-
cles provide a clear direction for the kinds of science and decision-making tools that could
make a big difference. While the ecological and economic modelling is challenging, the identi-
fication of clearly stated quantitative objectives over reasonable time intervals need not be, and
can be used along with the rules of thumb to inform better decision-making even under sub-
stantial uncertainties.
June: Neurobiology by Piali Sengupta
Re-interpreting pheromone signaling
Negative results that call into question a previously proposed model are generally difficult to
publish unless they overturn a particularly high-profile finding. And yet, negative results are
critically important for the advancement of knowledge; if a model isn’t supported by further
experiments it must be reconsidered.
For the PLOS Biology XV Collection, I’ve chosen to highlight a 2013 article by Gomez-Diaz
et al., “Ligands for pheromone-sensing neurons are not conformationally activated odorant
binding proteins” [10]. This article experimentally addresses a previously published model for
how a pheromone signals via its receptor in the fruit fly Drosophila melanogaster [11]. Negative
data from Gomez-Diaz and colleagues indicated that this proposed model is likely incorrect.
Pheromones are small molecules that mediate intraspecific chemical communication and
convey information about an individual’s social status, health, and sex, among others. In the
individual that receives the signal, pheromones elicit long-term changes in physiology and
development, as well as rapid changes in behavior. Decoding the complex language of phero-
mone signaling remains an ongoing challenge.
Pheromones play a particularly critical role in the lifecycles of insects. In Drosophila, the
male-specific pheromone cis-vaccenyl acetate (cVA) regulates courtship and aggression behav-
iors. This pheromone is sensed via the Or67d olfactory receptor, which expressed in a subset
of olfactory sensory neurons (OSNs) located in the T1 trichoid sensilla on the fly’s antennae.
Odorant-binding proteins (OBPs) are diverse proteins that facilitate the presentation of
odorants to their cognate receptors, but aren’t thought to directly bind the receptors them-
selves. cVA signaling via Or67d requires an OBP called LUSH. Previous work had shown that
in the absence of LUSH, basal spiking of Or67d-expressing OSNs decreased, leading to the
hypothesis that LUSH may directly bind Or67d and thereby modulate OSN firing.
Laughlin et al [11] experimentally tested this hypothesis by generating a presumed constitu-
tively active recombinant LUSH protein (LUSHD118A). They then infused this recombinant
protein into the sensilla of lush mutant flies by including the recombinant protein in the
recording pipet. This protein was found to dramatically increase spontaneous firing of the
Or67d neurons; activity was not further increased upon cVA addition. These data were inter-
preted to support the notion that LUSH acts directly on Or67d.
Gomez-Diaz and co-workers used a different experimental approach to test this model.
They generated transgenic flies expressing LUSHD118A, the same presumed constitutively
active mutant, at endogenous levels under the control of lush regulatory sequences. The trans-
genic LUSHD118A did not result in the enhanced OSN activity that Laughlin et al. had
observed in the infusion experiment. Moreover, these neurons retained the ability to be acti-
vated by cVA, and lush mutant flies expressing additional LUSH mutant proteins at endoge-
nous levels didn’t recapitulate the increased or decreased cVA sensitivity shown by Laughlin
et al.
What could account for this discrepancy? Recombinant LUSH protein purified from bacte-
ria may have different properties than endogenously produced protein. Acute presentation of
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LUSH proteins at non-physiological concentrations may also have elicited non-physiological
effects. Indeed, an independent transgenic strain expressing LUSHD118A [12] also failed to
recapitulate the infusion results.
The negative results reported by Gomez-Diaz and co-workers indicated that LUSH is
unlikely to directly activate Or67d in the manner proposed in previous publications. This arti-
cle doesn’t include new experiments addressing LUSH function, and indeed the role of LUSH
in pheromone signaling remains mysterious to this day. But by presenting these negative data,
the work described by Gomez-Diaz et al is important as it rules out one potential hypothesis
and allows the field to continue exploring exactly how pheromones collaborate with OBPs to
elicit specific behaviors.
July: Structural biology by Ann Stock
Anatomy of a protein kinase spine and how to break it
The post-translational addition of phosphate groups to serine, threonine and tyrosine residues
is a fundamental strategy for regulating protein activities in eukaryotes. Eukaryotic protein
kinases—the enzymes that catalyze these modifications—are critical to cellular function, and
aberrant kinase activities are associated with many diseases including cancer, inflammation,
infection, diabetes, hypertension, and neurodegeneration.
Eukaryotic protein kinases are therefore important targets for therapeutic intervention,
now constituting a quarter of all drug discovery and development efforts, and ranking second
only to G-protein-coupled receptors (GPCRs) as pharmaceutical targets. More than three
dozen kinase inhibitors have received FDA approval since 2001, when Imatinib (Gleevec), an
inhibitor of bcr-abl kinase, was approved for treatment of chronic myelogenous leukemia
(CML). Rational drug design has played an essential role in kinase inhibitor development,
with molecules being designed to target specific kinase conformations. Understanding the
structural basis for regulation of protein kinase activity is therefore key to these efforts.
For the PLOS Biology XV Collection, I’ve chosen to highlight an article from the laboratory
of Susan Taylor [13] that defines a set of intramolecular interactions that distinguish inactive
and active conformational states of eukaryotic protein kinases. Such classification is compli-
cated, because unlike many enzymes, eukaryotic kinases do not have single discrete active and
inactive conformations, but instead are dynamic, with multiple conformations populating the
two functional states.
The catalytic core of eukaryotic protein kinases consists of conserved N- and C-lobes with
the active site located at the interface of these two lobes. Previous studies had identified three
hydrophobic features in the catalytic core: the αF-helix in the C-lobe and two clusters of non-
contiguous residues in the primary sequence that coalesce in the three-dimensional structure
to form two hydrophobic “spines” that span the N- and C-lobes. The Catalytic (C) spine
includes the adenine moiety of bound ATP, which bridges hydrophobic residues in the N- and
C-lobes. The Regulatory (R) spine, which typically consists of two aromatic residues in the C-
lobe (RS1 and RS2) and two aliphatic residues in the N-lobe (RS3 and RS4), runs parallel to
the C-spine, is aligned in a contiguous hydrophobic patch in the active state, and is disassem-
bled in the inactive state (Fig 7).
Meharena and colleagues examined R-spine residues in the sequences of ~13,000 kinases
and tested hypotheses about the nature of these residues by mutational analyses of the repre-
sentative kinase cAMP-dependent protein kinase (PKA). They observed that residues RS1 and
RS2 in the C-lobe were extremely sensitive to mutation, in contrast to the relative robustness
of residues RS3 and RS4 in the N-lobe. This led to the identification of a set of three highly
conserved residues that surround RS3 and RS4. These residues that support the R-spine in the
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N-lobe were dubbed Shell residues Sh1, Sh2 and Sh3. Additional mutational analyses provided
experimental validation of the hypothesis that integrity of the R-spine is essential for catalysis.
Furthermore, the data provided evidence that phosphorylation of the activation loop promotes
activation by stabilizing the R-spine.
Knowing that an assembled R-spine is required for an active state, the group examined
available structures of eukaryotic protein kinases and identified 172 structures in which R-
spines were disassembled. They were able to classify four specific ways in which the R-spine
was broken. Two of these correlated with previously characterized inactive conformations
Fig 7. A figure from Meharena et al. showing the R-spine configuration in the active state (center) and four different inactive conformations.
Cartoon depictions of representative kinase structures are shown alongside schematic representations of the N- and C-lobes, with the C-spine
depicted in gold, R-spine residues depicted in burgundy, and Shell residues in teal. Image reproduced under CC-BY 4.0 license, credit: 10.1371/
journal.pbio.1001680.
https://doi.org/10.1371/journal.pbio.3000180.g007
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associated with positioning of the DFG motif in the activation loop. One conformation
involves a DFG-out orientation, and the other, a DFG-in orientation caused by movement of
the αC-helix. These two inactive conformations have already been successfully targeted for
drug development.
The description of additional inactive conformations provides opportunities for new strate-
gies for drug design and a broader foundation for interpreting and perhaps eventually modulat-
ing the molecular defects caused by protein kinase mutations associated with human disease.
August: Infectious diseases by Andrew Read
Perverse outcomes of novel therapies
Yale professor Steve Stearns once warned that the transition from Young Turk to Old Turkey
happens quickly. He was right. Being an Old Turkey has challenges, not least that you more
readily spot ignorance but you have less bandwidth to think it through. So, it is a total joy to
come across an analysis you wish you’d had time to do yourself. The article I have chosen for
the PLOS Biology XV Collection is one of those. In a 2014 Essay [14], three Young Turks—
Pedro Vale, Andy Fenton and Sam Brown—considered a strategy said by others to be a solu-
tion to one of the great health challenges of the 21st century. Before their article, all I could see
was a jumble of plusses and minuses. They sorted that out.
Prompted by the antimicrobial resistance crisis–said by some to be a bigger threat to humanity
than terrorism–the search is on for drugs that can treat patients infected with resistant bugs–ide-
ally without causing resistance themselves. One idea is to find drugs which make bugs less lethal
(for example, by inactivating secreted bacterial toxins) or by making the patient more robust (for
example, by enhancing tissue repair). The thinking is that such drugs would make the patient feel
better and–because the bug is allowed to survive–resistance evolution won’t ensue (Fig 8).
The claim that these ‘damage-limitation’ drugs would be evolution-proof set off alarm bells
in my head when I first heard it soon after the turn of the century. The only thing that stops
evolution is death. Otherwise, as actor Jeff Goldblum put it in Jurassic Park, “Life, uh, finds a
way.” Vale et al. provide what I consider the first sensible analysis of the epidemiological and
evolution consequences of damage-limiting drugs. In a few pithy paragraphs (and seven lines
of algebra), they show there are many possible consequences, not all of which are good. Most
immediate are the transmission consequences. Not only will bugs be left alive to transmit, but
infectious people will be harder to spot and, being less sick, more likely to be in contact with
susceptible people. And the evolutionary outcomes also need not be good. For instance, if
toxin production gives pathogens fitness advantages, as it almost always does, inactivating tox-
ins with drugs might select for bugs that produce more toxin than the drugs can deal with–or
bugs that can produce other toxins. None of those potentially harmful outcomes have to even-
tuate, as Vale et al. make clear, but they very well might.
The risk of harm is not an argument against developing damage-limiting drugs. But it is a
strong argument for not considering them as magic bullets. Just like conventional drugs, their
impact on pathogen transmission and evolution needs to be studied at all stages of the discov-
ery pipeline–and post-roll out. Vale et al. provide the roadmap for things to look for. It’s an
article I wish I’d written.
September: Evolutionary biology by Harmit Malik
Living l’AVIDA loca—Origins of multicellularity
Even before John Maynard Smith formalized the term, evolutionary biologists have been fasci-
nated by major evolutionary transitions, including the transition from single-celled to
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multicellular organisms. Multicellularity occurs over and over in the evolutionary record, giv-
ing rise to the bounty of life-forms visible to the naked eye. Simple, undifferentiated multicel-
lularity can be easily explained as an example of practical cooperation, wherein different
single-celled entities pool resources in a multicellular commune while preserving their individ-
uality and the right to procreate.
However, differentiated multicellularity involves a Faustian bargain, akin to eusocial insect
societies with few queens and many workers. What gives rise to such reproductive division of
labor between differentiated non-reproductive cells that make up the soma and the few repro-
ductive germ cells that are capable of giving rise to new offspring? The ‘dirty work’ hypothesis
proposed that the pressures of doing ‘work’ (cell division, metabolic activity) are inherently
mutagenic, and therefore likely to compromise genomic integrity. Thus, sequestration of cells
dedicated to the task of reproduction absolves them of ‘dirty work’ which keeps their genomes
as pristine as possible, and thus leads to the germ-soma dichotomy.
Despite being elegant and powerful in its simplicity, the ‘dirty work’ hypothesis is neverthe-
less tricky to test since it would require capturing the transition to differentiated multicellular-
ity in the act. In recent years, experimental evolution models have made significant advances
in our understanding of transitions to undifferentiated multicellularity in many unicellular
organisms (yeast, Volvox, Chlamydomonas, choanoflagellates) but reproductive differentiation
remains elusive. Enter AVIDA, a powerful artificial life software platform designed by Charles
Ofria, Chris Adami, and C. Titus Brown, to study the evolutionary biology of self-replicating
and evolving digital cells, self-replicating computer programs that evolve in an open-ended
fashion.
In a fascinating article published in 2014 in PLOS Biology, Heather Goldsby and colleagues
created a world of 400 multicells in the AVIDA platform [15] (Fig 9). Each multicell is akin to
a multicellular organism, and comprises individual digital cells, performing a combination of
logic functions, which ultimately determines how many resources flow into the multicell, and
thereby its ability to replicate. Into this system of multicellular ‘organisms,’ the authors intro-
duced a mutation rate into individual cells, which allowed them to acquire new functions and
therefore more resources but also increased the probability of ‘genomic’ damage. Intriguingly,
as the authors vary the mutation rate, they find ‘somatic’ cells incapable of self-replication at
intermediate mutation rates. Closer examination confirms that these somatic cells are indeed
performing more metabolic functions (‘dirty work’) and therefore taking a bigger hit to their
genome integrity, whereas ‘germ’ cells maintain their own, and therefore the multicell’s,
genetic information in pristine condition.
The authors exploit the power of AVIDA by following individual lineages of multicells (and
their constituent cells) to find that multicells almost always first favor the development of
‘pseudo-somatic’ cells that perform much higher metabolic functions and therefore increase
organismal (multicell) fitness. These ‘pseudo-somatic’ cells subsequently lose their ability to
self-replicate, thereby avoiding a catastrophe of genomic mutation in the organism. Thus, a
division of labor between ‘dirty work’ and reproduction is the most successful long-term strat-
egy for multicellular organisms. Indeed, acquisition of somatic cells also allowed multicells to
explore previously forbidden phenotypic niches under conditions in which mutational load
increases with every new function. One can easily imagine that an increase in body size and
complexity may represent such a mutational ramp-up. Another elegant article in PLOS Biology
Fig 8. The effect of damage limitation mechanisms on the loss of host health during infection. One can imagine
several relationships between increasing pathogen load and host health, which may be infection- or pathogen-
specific. Image reproduced under CC-BY 4.0 license, credit: 10.1371/journal.pbio.1001769.
https://doi.org/10.1371/journal.pbio.3000180.g008
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[16] nicely demonstrates that preservation of mitochondrial genome integrity and quality is
one example of how germ cells in a multicellular organism may avoid the cost of ‘dirty work’
paid by the soma.
Despite involving digital life-forms, experiments such as those performed by Goldsby et al.
are an excellent example of the extraordinary insight they provide into evolutionary transitions
that might otherwise be impossible to study with living, biological organisms. Cooperative sys-
tems such as multicellular organisms always operate under peril of cheaters, mutation-laden
somatic cells that do not cede the reproductive role to pristine germ cells. However, the
authors show that multicellular organisms comprising these high-mutation cells are less fit.
Thus, their experiments not only provide valuable insight into ancient evolutionary transitions
to multicellularity but may also guide studies of reversion to unicellularity, whereby cancerous
cells arise by flouting rules governing replication or quiescence in multicellular organisms.
October: Plant biology by Mark Estelle
Auxin transport—More a river delta than a stream
The sessile lifestyle of plants is enabled by remarkable developmental plasticity. Plant form is
affected by a wide range of environmental conditions from nutrient availability to herbivory,
so two plants with the same genotype can appear quite different, depending on their environ-
ment. All plant organs and tissues are derived from dispersed stem cell populations called mer-
istems. Individual meristems can act independently to a certain extent but are also controlled
by systemic signals that coordinate and integrate their activities. The identity of these signals
and how they function, has long been a subject of intense interest to plant biologists. The arti-
cle that I chose to highlight for the PLOS Biology XV Collection is by Tom Bennett, Ottoline
Leyser and colleagues and provides important new insight into the nature of systemic commu-
nication [17].
One of the best systems for understanding how plant development is coordinated is the
behavior of meristems that are found in the axil of each leaf. These axillary meristems often
persist in a dormant state, as buds, until such time as they are activated. For example, if the
shoot tip is removed by herbivory or with a pair of scissors, bud dormancy is released, and a
branch is produced. This phenomenon, called apical dominance, depends upon movement of
the plant hormone auxin from the apex of the plant down through the stem. It is well known
that auxin moves via a specific transport system called the polar auxin transport stream or
PATS. PATS acts to rapidly move auxin through files of cells in the stem, specifically the xylem
parenchyma and vascular cambium, from the plant apex down into the root system. Auxin
transport requires one of a family of auxin cellular efflux carriers called the PIN-FORMED
Fig 9. Over evolutionary time, multicells change from consisting entirely of germ cells (A) to consisting of a
blend of germ and soma cells (D), where germ cells serve as propagules (founders for a new multicell) and soma
cells perform the mutagenic work. (A) Germ cells do not perform mutagenic work. (B) Germs cell do perform
mutagenic work. (C) A subset of germ cells performs mutagenic work. (D) Soma cells, but not germ cells, perform
mutagenic work. Image reproduced under CC-BY 4.0 license, credit: 10.1371/journal.pbio.1001859.
https://doi.org/10.1371/journal.pbio.3000180.g009
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(PIN) proteins. Polar transport is the result of localization of the PIN1 transporter to the basal
side of the cell.
Over the last decade, the Leyser group has performed elegant studies to explain how PATS
regulates shoot branching (Fig 10). For bud activation to occur, a PATS must be established
that transports auxin from the bud into the existing PATS in the stem. This appears to happen
through a canalization process in which passive auxin transport from a source to a sink, upre-
gulates and polarizes PIN transporters leading to formation of narrow polarized transport
stream. Whether or not this happens depends on the source-sink relationship between the bud
and the stem PATS. If auxin levels in the PATS are high, it will be a weak sink and transport
from the bud will not occur. In contrast, if auxin levels are low, as is the case after decapitation,
the stem PATS will be a strong sink, leading to establishment of a new PATS from the activat-
ing bud into the stem. It’s important to note that the PATS is sensitive to many other factors
besides decapitation (a dramatic environmental stimulus) including light, nutrient availability
and the genetic program. In this way the PATS functions as a central integrator of shoot
branching control.
Although both experimental and mathematical modeling approaches support this model, it
does not explain all aspects of branching regulation. For example, buds on opposite sides of
the stem will transport auxin into different vascular bundles, yet still inhibit each other’s acti-
vation. To try to explain this sort of behavior, Bennett et al. explored the possibility that other
auxin transport streams may exist in the stem. In particular, they investigated the role of other
members of the PIN family in branching regulation. Their results indicate that auxin transport
is much more complex than previously proposed. In addition to PIN1-based highly polar
transport, PIN3, PIN4, and PIN7 contribute to widespread and less polar auxin transport,
Fig 10. Two proposed models of auxin transport in an Arabidopsis stem. Image reproduced under CC-BY 4.0
license, credit: 10.1371/journal.pbio.1002446.
https://doi.org/10.1371/journal.pbio.3000180.g010
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which they term “connective auxin transport” (CAT). Modeling studies demonstrate that CAT
provides important local information that helps to coordinate the behavior of axillary meri-
stems that are close together.
This work is extremely satisfying because it takes us beyond the simplistic view of polar
auxin transport that has dominated the field for decades to a more complex understanding of
how meristems communicate through local and long-distance movement of auxin.
November: Developmental biology by Sally Lowell
A spotlight on spottiness
Let’s start with a remarkable fact. Cells can, under the right conditions, organise themselves
into patterns without any outside instruction. Indeed, it is the ability of cells to self-organise
that makes multicellular life possible. Contemplating this, it soon becomes apparent that the
only proper course of action is to become a developmental biologist and devote one’s life to
trying to understand how such things can possibly happen.
This phenomenon captured the imagination of mathematician and code-breaker Alan
Turing, who famously described one mechanism for the spontaneous emergence of periodic
patterns. In a “Turing mechanism” the initially uniform secretion of a diffusible ‘activator’
molecule triggers the production of a faster-diffusing ‘inhibitor.’ Over time, instabilities in the
system become amplified until these molecules resolve into patterns. Examples of such pat-
terns might include the stripes of a tiger or the spots of a leopard. Even non-leopards such as
you and I have a spotty distribution of hair follicles in our skin, following a pattern that could
be explained by a Turing mechanism.
In the article that I’ve chosen to highlight for the PLOS Biology XV Collection, Glover et al
[18] set out initially to identify the components of the putative Turing mechanism that patterns
hair follicles. The authors used a beautiful live explant system that allowed them to follow pat-
terning in real time. They successfully homed in on a signalling network that seemed to be suf-
ficient to explain the distribution of hair follicles. They then observed that the first ‘pre-
pattern’ emerges within the epidermal layer of the skin, and this then dictates the position of
mesenchymal condensates—groupings of mesenchymal cells necessary for the formation of a
new hair follicle—in the underlying dermis.
So far, so good: the pattern is explained. Now comes the surprise. Because the authors now
knew which particular signals drive Turing patterning, they were able to disrupt the distribution
of these signals and show that this wipes out the epidermal prepattern. Unexpectedly, a suitably
spotty distribution of condensates still somehow emerged in the dermis. At first this looked
very similar to the usual Turing pattern, but Glover et al noticed a few tell-tale differences.
Instead of lining up neatly along cut edges of explants, spots now seem to avoid sitting too close
to these edges. The dynamics of patterning was also altered. These careful observations, com-
bined with modelling, suggested that this epidermis-independent spottiness was driven not by
Turing patterning (which you’ll remember is driven by diffusion of activator and inhibitor mol-
ecules) but by a conceptually similar but mechanistically distinct mode where it is cells rather
than molecules that move. The authors found that patterning is driven through local aggrega-
tion of cells. This clustering becomes reinforced locally as cells draw closer to each other and is
inhibited more distantly because cells become sparser as they move away from the future inter-
follicular regions and towards the aggregates (Fig 11). Glover et al went on to identify the mole-
cules that mediate this previously-cryptic mesenchymal self-organisation process and to reveal
how it is linked with epidermal Turing patterning in a hierarchical process.
These findings have implications beyond explaining our hairiness. They make us look with
a fresh eye at other patterning processes and wonder whether there may be additional cryptic
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mechanisms lurking undiscovered behind our textbook models. For example, it has long been
known that patterning at gastrulation is dictated in mammals by signalling centres in the extra-
embryonic tissues, so it came as a shock when it was recently discovered that similar patterns
somehow still emerge within aggregates of pluripotent cells even in the absence of extraembry-
onic tissues [19–22]. Are there two distinct but interlinked mechanisms operating at gastrula-
tion, just as there are in the skin?
The study raises a number of other questions. Is the cryptic “secondary” patterning mecha-
nism merely a remnant of evolutionary history, or could it be important for ensuring that pat-
terning is robust? Could the principle of using multiple interacting patterning mechanisms be
useful in guiding efforts to engineer patterns into groups of cells [23]? Perhaps the broadest les-
son here is that we should not rush to decide between apparently competing hypotheses on the
assumption that one of them must be wrong. Sometimes biology really does let us have it both
ways.
December: Meta-research by Jonathan Kimmelman
Ethical oversights in ethical oversight of animal research
Sometimes the life sciences work fantastically, as when insights into fundamental processes are
transformed into life-saving treatments. Other times the scientific process flops: false claims
take on a life of their own [24,25], or ineffective treatments are advanced into drug develop-
ment [26] and/or care [27]. A key to improving the balance of successes versus failures is the
systematic investigation of how science works—a line of inquiry known as meta-research.
PLOS Biology is the only general life science journal to offer strong support for this project by
devoting a specific section to meta-research reports.
Fig 11. Two models explaining the emergence of repeating patterns and a schematic of the process of hair follicle
formation. Image reproduced under CC-BY 4.0 license, credit: 10.1371/journal.pbio.2002117.
https://doi.org/10.1371/journal.pbio.3000180.g011
PLOS Biology | https://doi.org/10.1371/journal.pbio.3000180 February 27, 2019 19 / 22
Among the many excellent meta-research articles published by PLOS Biology, I’ve chosen
to highlight Vogt et al [28] for the XV Collection. It stands out for offering a glimpse of
research evaluation processes that are all but inaccessible to systematic analysis because they
typically occur behind the closed doors of institutional review panels.
First some background: since roughly the 1970s, various government authorities have
required that research proposing to use nonhuman animals undergo an independent review
and approval process before it is conducted. Such review processes stem from the ethical sensi-
tivities surrounding experiments that use nonhuman animals as their research reagents.
Unlike rocks, chemicals in the Sigma catalogue, or subatomic particles, animals have a capacity
for suffering and their interests must be protected. Animal care committees are charged with
making an independent judgement about whether nonhuman animal studies are morally justi-
fied. Yet the documentation submitted to these committees is deemed confidential and little is
known about precisely what factors drive those judgements.
In Vogt et al, the authors accessed almost 1300 applications to conduct animal experiments
in Switzerland, a jurisdiction where reviewers on animal care committees are instructed to
weigh an experiment’s harms against its potential benefits. Outside of Switzerland, access to
such protocols is almost impossible; indeed, researchers often aren’t even required to provide
a detailed research protocol.
The authors then examined the extent to which these application protocols described the
implementation of practices aimed at addressing threats to the internal validity of experiments.
These practices are important safeguards against faulty experimental design and researcher
bias. Vogt et al found that few applications stated an intention to use procedures like randomi-
zation or concealed allocation. Such practices were only slightly more common for studies
involving “higher” nonhuman animal species like cats, dogs, and primates. But even here, they
were uncommon. For example, fewer than 20% of such studies proposed a blinded study
design. The authors conclude that animal care committees in Switzerland approve experiments
based not on an appraisal of the scientific methods, but rather on confidence, based perhaps
on the scientific bona fides of researchers and/or sponsors.
Regretfully, the lack of rigorous evaluation of proposed research seems to extend to human
research ethics committees as well. In 2018, PLOS Biology published an article by Wieschowski
et al examining the preclinical justification for 106 early phase clinical trial protocols submitted
for institutional review boards (IRBs) at German institutions [29] (disclosure: I am a middle
author on this publication). The report found that 17% of protocols did not cite any preclinical
efficacy studies. Those protocols that did cite preclinical efficacy studies offered scant informa-
tion on the extent to which such studies had addressed various threats to clinical generalizabil-
ity. One logical implication of this report is that—as with nonhuman animal studies in Vogt
et al—ethics review committees approve early phase trials without a clear appraisal of their evi-
dentiary grounding. Instead they rely on confidence in the researchers, sponsors, or perhaps
other regulatory processes.
Scores of studies have previously documented deficiencies in the methods described in pre-
clinical study publications. What makes Vogt et al stand out from these other studies, however,
is that such deficiencies are documented farther upstream—at the point where studies are
designed and reviewed.
Vogt et al (and Wieschowski et al, too) has other, more profound implications. Nonhuman
animal and human experiments may look as if they are entirely conceived of and designed by
scientists and research sponsors. Yet IRBs and animal care committees—far from mere
bureaucratic after-thoughts—play a critical role in shaping what questions are asked in
research and how such questions are resolved. Among other things, such committees grant sci-
entists the moral license for pursuing research that might otherwise be deemed inhumane or
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unethical. In so doing, they signal to scientists and others what sorts of research practices are
proper and which ones are not, and scientists who want to get their protocols approved quickly
learn to internalize these norms.
Yet such committees process large volumes of highly technical research protocols and must
rely on heuristics for assessing the relationship between a study’s burden and its value.
Whether that is “confidence”” (as alleged by Vogt et al) or precedent, it’s hard to avoid con-
cluding that many aspects of ethical review in life science research contradict the spirit of inde-
pendent, systematic and unbiased risk/benefit analysis enshrined in various policy documents.
If the life sciences suffer from an excess of unreproducible findings, the ethical oversight (in
both senses of the term) is partly to blame.
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